Neuromyelitis Optica Spectrum Disorders
📧 Sign up to get email alerts when something new happens for Neuromyelitis Optica Spectrum Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders [Phase 1]
A Phase 1 clinical trial assessing the safety and efficacy of NouvSoma001 for neuromyelitis optica spectrum disorders is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
Beijing Tiantan Hospital is conducting an ongoing enrollment study to establish normal Chinese lifespan brain charts, enrolling by invitatio…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)
A prospective cohort study investigating neuromyelitis optica spectrum disorders (NMOSD) is listed as not yet recruiting, sponsored by Xiame…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
An ongoing sponsor-initiated study is evaluating metabolism, connectivity, and ultra-high-field mesoscopic imaging to uncover mechanisms of …
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD [Phase 3]
Phase 3 trial update examining slow vs rapid glucocorticoid tapering in NMOSD patients treated with inebilizumab. The study is not yet recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy [Phase 1]
Phase 1 clinical trial investigating C-CAR168 for autoimmune diseases refractory to standard therapy is currently recruiting, covering SLE, …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder [NA]
Clinical trial status update indicates a study evaluating Protein A immunoadsorption for acute episodes of Neuromyelitis Optica Spectrum Dis…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: HANDLE-a Real World Study on Satralizumab in NMOSD
A real-world study assessing satralizumab for neuromyelitis optica spectrum disorders is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. [NA]
This clinical trial update reports on the frequency of FCGR3A gene polymorphisms in patients with Neuromyelitis Optica Spectrum Disorders, M…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. [EARLY_Phase 1]
A Phase 1 trial evaluating universal CAR-T cells for refractory autoimmune diseases of the nervous system; the study is not yet recruiting.